60 Degrees Pharmaceuticals files Form 3 showing Knight Therapeutics stake of 658,629 shares

Knight Therapeutics filed a Form 3 with the SEC, disclosing ownership of 658,629 shares of common stock in 60 Degrees Pharmaceuticals. The filing identifies Knight Therapeutics as a 10% owner of the company. This ownership position was reported as of July 22, 2026. The information was published via EDGAR on July 29, 2026.

Knight Therapeutics filed a Form 3 showing it holds 658,629 shares of 60 Degrees Pharmaceuticals common stock. * The filing identifies Knight Therapeutics as a 10% owner. * The ownership position was reported as of July 22, 2026. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. 60 Degrees Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-082796), on July 29, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here